vTv Therapeutics Inc
NASDAQ:VTVT

Watchlist Manager
vTv Therapeutics Inc Logo
vTv Therapeutics Inc
NASDAQ:VTVT
Watchlist
Price: 13.91 USD 7.58% Market Closed
Market Cap: 41.9m USD
Have any thoughts about
vTv Therapeutics Inc?
Write Note

P/OCF
Price to OCF

-1.9
Current
-150.3
Median
23.4
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-1.9
=
Market Cap
41.9m USD
/
Operating Cash Flow
-21.8m USD
All Countries
Close
Market Cap P/OCF
US
vTv Therapeutics Inc
NASDAQ:VTVT
41.9m USD -1.9
FR
Pharnext SCA
OTC:PNEXF
6T USD -234 903.4
US
Abbvie Inc
NYSE:ABBV
302.3B USD 18.3
US
Amgen Inc
NASDAQ:AMGN
160.6B USD 22.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.3B USD -133.8
US
Gilead Sciences Inc
NASDAQ:GILD
118.3B USD 11.8
US
Epizyme Inc
F:EPE
94.1B EUR -478.9
AU
CSL Ltd
ASX:CSL
138.5B AUD 32.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
90.4B USD 21.3
US
Seagen Inc
F:SGT
39.3B EUR -77.3
NL
argenx SE
XBRU:ARGX
33.4B EUR -136.5
 
US
vTv Therapeutics Inc
NASDAQ:VTVT
Average P/OCF: 21.3
Negative Multiple: -1.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -234 903.4
US
Abbvie Inc
NYSE:ABBV
18.3
US
Amgen Inc
NASDAQ:AMGN
22.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -133.8
US
Gilead Sciences Inc
NASDAQ:GILD
11.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.9
AU
CSL Ltd
ASX:CSL
32.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
21.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -77.3
NL
argenx SE
XBRU:ARGX
Negative Multiple: -136.5

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More